Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Simonneau

Showing results (231-240 of 240) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 240 results.
Revue Des Maladies Respiratoires|May 1, 2007
[Postembolic pulmonary hypertension]X Jais, P Dartevelle, F Parent, et al.
The European Respiratory Journal|July 9, 2011
The association between resting and mild-to-moderate exercise pulmonary artery pressureK Whyte, S Hoette, P Herve, et al.
The European Respiratory Journal|December 22, 2006
Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertensionF Perros, P Dorfmüller, R Souza, et al.
Thorax|September 2, 2005
Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertensionM C Tamby, Y Chanseaud, M Humbert, et al.
The European Respiratory Journal|August 10, 2010
Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in ratsL C Price, D Montani, C Tcherakian, et al.
Haemostasis|March 24, 1999
Early versus delayed introduction of oral vitamin K antagonists in combination with low-molecular-weight heparin in the treatment of deep vein thrombosis. a randomized clinical trial. The ANTENOX Study GroupC Leroyer, L Bressollette, E Oger, et al.
The European Respiratory Journal|June 22, 2010
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertensionM Humbert, O Sitbon, A Yaïci, et al.
The New England Journal of Medicine|August 4, 2001
Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasiaR C Trembath, J R Thomson, R D Machado, et al.
The European Respiratory Journal|September 15, 2009
Guidelines for the diagnosis and treatment of pulmonary hypertension, , , et al.
Revue Des Maladies Respiratoires|October 24, 2008
[Prolongation of anti vitamin K treatment for 18 months versus placebo after 6 months treatment of a first episode of ideopathic pulmonary embolism: a mutlicentre, randomised double blind trail. The PADIS-EP Trial]F Couturaud, G Pernod, C Pison, et al.
Pageof 24

Showing results (231-240 of 240) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 240 results.
Revue Des Maladies Respiratoires|May 1, 2007
[Postembolic pulmonary hypertension]X Jais, P Dartevelle, F Parent, et al.
The European Respiratory Journal|July 9, 2011
The association between resting and mild-to-moderate exercise pulmonary artery pressureK Whyte, S Hoette, P Herve, et al.
The European Respiratory Journal|December 22, 2006
Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertensionF Perros, P Dorfmüller, R Souza, et al.
Thorax|September 2, 2005
Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertensionM C Tamby, Y Chanseaud, M Humbert, et al.
The European Respiratory Journal|August 10, 2010
Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in ratsL C Price, D Montani, C Tcherakian, et al.
Haemostasis|March 24, 1999
Early versus delayed introduction of oral vitamin K antagonists in combination with low-molecular-weight heparin in the treatment of deep vein thrombosis. a randomized clinical trial. The ANTENOX Study GroupC Leroyer, L Bressollette, E Oger, et al.
The European Respiratory Journal|June 22, 2010
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertensionM Humbert, O Sitbon, A Yaïci, et al.
The New England Journal of Medicine|August 4, 2001
Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasiaR C Trembath, J R Thomson, R D Machado, et al.
The European Respiratory Journal|September 15, 2009
Guidelines for the diagnosis and treatment of pulmonary hypertension, , , et al.
Revue Des Maladies Respiratoires|October 24, 2008
[Prolongation of anti vitamin K treatment for 18 months versus placebo after 6 months treatment of a first episode of ideopathic pulmonary embolism: a mutlicentre, randomised double blind trail. The PADIS-EP Trial]F Couturaud, G Pernod, C Pison, et al.
Pageof 24